Table 4.
Characteristics of patients who had pre-alloBMT prospective MR studies who were included in risk factor analysis i.e. (Group1) (N=107) vs. all others who underwent alloBMT during the study period {N=226+ 11(Group2)}
| Characteristics | Patients with prospective pre-BMT MR studies(Group1) [n(%)] |
All others who underwent alloBMT during the study period [n (%)] |
P value |
|---|---|---|---|
| Gender | |||
| Male | 69(31.94) | 147(68.06) | 0.66 |
| Female | 38(29.69) | 90(70.31) | |
| Race | |||
| Other | 27(42.86) | 36(57.14) | 0.03 |
| Black | 24(35.29) | 44(64.71) | |
| White | 56(26.29) | 157(73.71) | |
| Diagnosis | |||
| Non-malignant | 18(26.47) | 50(73.53) | 0.36 |
| Malignant | 89(32.25) | 187(67.75) | |
| BMI at alloBMT1 | |||
| Normal | 62(35.63) | 112(64.37) | 0.08 |
| Underweight | 5(27.78) | 13(72.22) | |
| Overweight | 14(26.92) | 38(73.08) | |
| Obese | 23(51.11) | 22(48.89) | |
| Age at Transplant | |||
| ≤2 | 3(5.88) | 48(94.12) | <0.001 |
| 2 – 10 | 28(22.40) | 97(77.60) | |
| ≥10 | 76(45.24) | 92(54.76) |
1
Data from patients younger than 2 and patients who did not have height/weight measured at MR date were not included.
Abbreviations: MR, magnetic resonance; BMI at MR, body mass index percentile at the time of MR study